[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Booster do work", "description": "Booster doses probably needed by most people, unfortunately.\n\nhttps://ourworldindata.org/covid-vaccinations\n\nhttps://covid.cdc.gov/covid-data-tracker/#covidnet-hospitalizations-vaccination\n\nUS, 20.6 million so far\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html\n\nSix months after 2nd shot\n\n65 years and older\n\n50\u201364 years with underlying medical conditions\n\n18 \u2013 64 years, working / living in high-risk settings\n\n18 years and older, 2 months Johnson & Johnson/Janssen\n\nProtection of BNT162b2 Vaccine Booster against Covid-19 in Israel (NEJM, October 2021)\n\nhttps://www.medrxiv.org/content/10.1101/2021.08.27.21262679v1\n\nhttps://www.nejm.org/doi/full/10.1056/NEJMoa2114255?\n\nJuly 30, 2021, over 602\n\nThird (booster) dose of the Pfizer BNT162b2 vaccine was approved\n\n60 years or older who had been fully vaccinated\n\nAugust 29th, anyone over 12\n\nAt least five months previously\n\nN = 1,144,690\n\n2 dynamic cohorts\n\n2 vaccines only\n\nN = 5.2 million person days\n\n4,439 confirmed infections\n\n294 cases of severe covid\n(based on 4.6 million person days)\n\n2 vaccines + booster\n\nN = 10.6 million person days\n\n934 confirmed infections\n\n29 cases of severe COVID-19\n(based on 6.3 million person days)\n\n(despite older demographic)\n\nTwelve days or more after the booster dose\n\nIncreases antibody neutralization levels ~10-fold compared to after 2nd dose\n\n11.3 fold decrease in the relative risk of confirmed infection\n\nEfficacy among booster recipients to approximately 95%\n\n(May have waned to 50% with time and delta variant)\n\nhttps://www.medrxiv.org/content/10.1101/2021.08.24.21262423v1\n\n19.5 fold decrease in the relative risk of severe illness\n\nFactor reduction in reduced rate of confirmed infection in boosted versus none-boosted\n\nIn conjunction with safety reports\n\nthis study demonstrates the effectiveness of a third vaccine dose,\n\nin both reducing transmission and severe disease,\n\nindicates the great potential of curtailing the Delta variant resurgence by administering booster shots\n\nDecline in immunity, UK data\n\nhttps://www.gov.uk/government/news/over-eight-million-people-in-the-uk-receive-covid-19-booster-jabs\n\nProtection against symptomatic disease, Oxford/AstraZeneca vaccine  \n\n65%, up to 3 months after the second dose\n\n45% 6 months after the second dose\n\nProtection against symptomatic disease, Pfizer/BioNTech vaccine\n\n90% up to 3 months after 2nd dose\n\n65% 6 months after the second dose\n\nProtection against hospitalisation, Oxford/AstraZeneca vaccine \n\n95% at 3 months\n\n75% at 6 months \n\nProtection against hospitalisation, Pfizer/BioNTech\n\n99% at 3 months\n\n90% at 6 months\n\nWhy this is important\n\nA small change can generate a major shift in hospital admissions\n\nA change from 95% to 90% against hospitalisation would lead to doubling of admissions in those vaccinated\n\nEarly UK booster results from Pfizer\n\nBooster restores protection back up to \n\n95.6% against symptomatic infection\n\nBooster doses, Situation in UK\n\nhttps://www.gov.uk/government/news/over-eight-million-people-in-the-uk-receive-covid-19-booster-jabs\n\n8,115,229 boosted so far\n\nhttps://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-booster-vaccine/\n\nBooster vaccine doses, available on the NHS\n\nPeople most at risk from COVID-19,\n\nwho have had a 2nd dose of a vaccine at least 6 months ago\n\n(after 5 months for high risk groups)\n\nThis includes:\n\nAged 50 and over\n\nFrontline health / care workers\n\n16 and over with a health condition\n\n16 and over, carers or live with venerable people\n\nPregnant women in eligible groups\n\nCOVID-19 booster vaccine and flu vaccine\n\nIf you are offered both vaccines, it's safe to have them at the same time.", "link": "https://www.youtube.com/watch?v=MlUNsEqXZFU", "date_published": "2021-11-04 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Boosters and antivirals", "description": "DW interview well conducted by Brent as always, thank you", "link": "https://www.youtube.com/watch?v=LgidBCS2Nic", "date_published": "2021-11-04 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Global deaths under-reported", "description": "Under reporting of deaths, 19 months into the pandemic\n\nhttps://coronavirus.jhu.edu/map.html\n\nTotal deaths, 5,018,949\n\nTotal cases, 247,883,004\n\nTotal vaccine doses, 7,129,732,439\n\nWorld Health Organization\n\nhttps://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimating-global-excess-mortality\n\nBased on the excess mortality estimates produced for 2020\n\nwe are likely facing a significant undercount of total deaths directly and indirectly attributed to COVID-19\n\nMany countries still lack functioning civil registration and vital statistics systems\n\nPercentage of registered deaths\n\nhttps://www.who.int/data/data-collection-tools/score/dashboard#/\n\n98% in the European\n\n10% in the African region\n\nComparisons difficult\n\nExcess mortality\n\nThe difference in the total number of deaths in a crisis,\n\ncompared to those expected under normal conditions\n\nTherefore, includes direct and indirect impact\n\nWHO, 2020 data\n\nOfficial, 1,813,100\n\nLower bound, 3 million\n\nRegion of the Americas in 2020\n\nExcess mortality estimates range from 1.34 to 1.46 million\n\n60% more than reported\n\nEuropean Region in 2020\n\nExcess mortality estimates range from \n\n1.11 to 1.21 million\n\n50% more than reported\n\nhttps://www.economist.com/graphic-detail/coronavirus-excess-deaths-estimates\n\nExcess death calculations\n\nActual worldwide toll, 16.8 million excess deaths\n\n95% probability, 10.3 million to 19.5 million\n\nOfficial versus actual deaths (Economist)\n\nUS, deaths = 745,274\nUS, deaths = 860,000 to 1 million\n\nChina, deaths = 4,600\nChina, deaths = 150,000 to 1,700,000\n\nIndia, deaths = 458,000\nIndia, deaths = 1.2 million to 7.2 million\n\nRussia, deaths = 236,462\nRussia, deaths = 870,000 to 910,000\n\nIndonesia, deaths = 143,457\nIndonesia, deaths = 300,000 to 1.2 million\n\nPakistan, deaths = 28,477\nPakistan, deaths = 300,000 to 910,000\n\nBangladesh, deaths = 27,873\nBangladesh, deaths = 200,000 to 720,000\n\nTurkey, deaths = 71,052\nTurkey, deaths = 130,000 to 420,000\n\nMexico, deaths = 288,464\nMexico, deaths = 560,000 to 600,000\n\nBrazil, deaths = 608,071\nBrazil, deaths = 660,000 to 740,000\n\nFactors\n\nDeath tolls are heavily influenced by the age structure of a country\u2019s population\n\nRely on the assumption that officially published excess-mortality numbers are accurate\n\nCovid-19 disruption, some governments may have changed how they compile data\n\nInstitute for Health Metrics and Evaluation, University of Washington\n\nhttps://covid19.healthdata.org/global?view=cumulative-deaths&tab=trend\n\nTotal deaths are the estimated number of deaths attributable to COVID-19, including unreported deaths.\n\nReported and unreported deaths, 11.9 million", "link": "https://www.youtube.com/watch?v=hdmb5NFiEW0", "date_published": "2021-11-03 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]